Potentiation of olanzapine substitution in rats discriminating clozapine by the D2/3 agonist quinpirole

Behavioural Pharmacology

Volumn 18, Issue 3, 2007, Pages 185-190

  Cole, Jon C ^a   Field, Matt ^a   Sumnall, Harry R ^b   Goudie, Andrew J ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

Author keywords

Atypical antipsychotics; Clozapine; D2 and D3 receptors; Drug discrimination; Incentive salience; Olanzapine; Quinpirole; Rat

Indexed keywords

CLOZAPINE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; NEUROLEPTIC AGENT; OLANZAPINE; QUINPIROLE;

ANIMAL EXPERIMENT; ARTICLE; BIOASSAY; CONTROLLED STUDY; DRUG DISCRIMINATION; DRUG MECHANISM; DRUG POTENTIATION; DRUG SUBSTITUTION; FEMALE; NONHUMAN; QUANTITATIVE ASSAY; RAT; SCHIZOPHRENIA; STIMULUS RESPONSE;

ANIMALS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CLOZAPINE; DISCRIMINATION (PSYCHOLOGY); DISCRIMINATION LEARNING; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FEMALE; QUINPIROLE; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3;

EID: 34247253866     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e32813c5475     Document Type: Article

References (40)

1. Arnt J, Skarsfeldt T (1998). Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology 18:63-101.
2. Berridge K (2007). The debate over dopamine's role in reward: the case for incentive salience. Psychopharmacology (in press).
3. Bruhwyler J, Liegeois JF, Bergman J, Carey G, Goudie A, Taylor A, et al. (1997). JL13, a pyridobenzoxazepine compound with potential atypical antipsychotic activity: a review of its behavioural properties. Pharmacol Res 36:255-264.
4. Bymaster FP, Calligaro DO, Falcone JF, Marsh RD, Moore NA, Tye NC, et al. (1996). Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 14:87-96.
5. Carey G, Bergman J (1997). Discriminative-stimulus properties of clozapine in squirrel monkeys: comparison with conventional and novel antipsychotic drugs. Psychopharmacology 132:261-269.
6. Cohen C, Sanger DJ, Perrault G (1997). Characterization of the discriminative stimulus produced by the dopamine antagonist tiapride. J Pharmacol Exp Ther 283:566-573.
7. Colpaert FC, Niemegeers CJ, Janssen PA (1976). Theoretical and methodological considerations on drug discrimination learning. Psychopharmacologia 46:169-177.
8. Cook CD, Beardsley PM (2004). Modulation of the discriminative stimulus effects of mu opioid agonists in rats: II. Effects of dopamine D2/3 agonists. Behav Pharmacol 15:75-83.
9. 1A agonists and the antipsychotics clozapine, ziprasidone and S 16924, but not haloperidol, to the discriminative stimulus elicited by PD 128,907 and 7-OH DPAT. Neuropharmacology 40:899-910.
10. Dekeyne A, Iob L, Millan MJ (2003). Generalization of clozapine as compared to other antipsychotic agents to a discriminative stimulus elicited by the serotonin (5-HT)2A antagonist, MDL100,907. Neuropharmacology 44:604-615.
11. Desai RI, Terry P, Katz JL (2003). Comparison of the discriminative- stimulus effects of SKF 38393 with those of other dopamine receptor agonists. Behav Pharmacol 14:223-228.
12. Franken I, Hendricks V, Stam C, Van der Brink W (2004). A role for dopamine in the processing of drug cues in heroin dependent patients. European Neuropsychopharmacology 14:503-508.
13. Galineau L, Wilson AA, Garcia A, Houle S, Kapur S, Ginovart N (2006). In vivo characterization of the pharmacokinetics and pharmacological properties of [11C]-( +)-PHNO in rats using an intracerebral beta-sensitive system. Synapse 60:172-183.
14. Goudie AJ, Taylor A (1998). Comparative characterisation of the discriminative stimulus properties of clozapine and other antipsychotics in rats. Psychopharmacology 135:392-400.
15. Goudie AJ, Smith JA, Taylor A, Taylor MA, Tricklebank MD (1998). Discriminative stimulus properties of the atypical neuroleptic clozapine in rats: tests with subtype selective receptor ligands. Behav Pharmacol 9:699-710.
16. Goudie AJ, Cooper GD, Cole JC, Sumnall HR (2007). Cyproheptadine resembles clozapine in vivo following both acute and chronic administration in rats. J Psychopharmacol 21:179-190.
17. Goudie AJ, Smith JA, Cole JC (2004a). Stimulus properties of the 'atypical' antipsychotic zotepine in rats: comparisons with clozapine and quetiapine. Pharmacol Biochem Behav 77:163-173.
18. Goudie AJ, Smith JA, Millan MJ (2004b). Characterization of the effects of receptor-selective ligands in rats discriminating the novel antipsychotic quetiapine. Psychopharmacology 171:212-222.
19. Kapur S (2004). How antipsychotics become anti-'psychotic': from dopamine to salience to psychosis. Trends Pharmacol Sci 25:402-406.
20. Kapur S, Mizrahi R, Li M (2005). From dopamine to salience to psychosis: linking biology, pharmacology and phenomenology of psychosis. Schizophr Res 79:59-68.
21. Kapur S, Agid O, Mizrahi R, Li M (2006). How antipsychotics work: from receptors to reality. NeuroRx 3:10-21.
22. Kelley BM, Porter JH (1997). The role of muscarinic cholinergic receptors in the discriminative stimulus properties of clozapine in rats. Pharmacol Biochem Behav 57:707-719.
23. Lieberman JA, Tollefson G, Tohen M, Green AI, Gur RE, Kahn R, et al. (2003). Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol. Am J Psychiatry 160:1396-1404.
24. McEvoy JP, Lieberman JA, Stroup TS, Davis SM, Meltzer HY, Rosenheck RA, et al. (2006). Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. Am J Psychiatry 163:600-610.
25. McMahon LR, Cunningham KA (2003). Discriminative stimulus effects of ( - )-ephedrine in rats: analysis with catecholamine transporter and receptor ligands. Drug Alcohol Depend 70:255-264.
26. Millan MJ, Schreiber R, Monneyron S, Denorme B, Melon C, Queriaux S, Dekeyne A (1999). S-16924, a novel, potential antipsychotic with marked serotonin1A agonist properties. IV. A drug discrimination comparison with clozapine. J Pharmacol Exp Ther 289:427-436.
27. 2- adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine and 11 other antipsychotic agents. J Pharmacol Exp Ther 292:54-66.
28. Mizrahi R, Bagby RM, Zipursky RB, Kapur S (2005). How antipsychotics work: the patients' perspective. Prog Neuropsychopharmacol Biol Psychiatry 29:859-864.
29. Mizrahi R, Kiang M, Mamo DC, Arenovich T, Bagby RM, Zipursky RB, Kapur S (2006). The selective effect of antipsychotics on the different dimensions of the experience of psychosis in schizophrenia spectrum disorders. Schizophr Res 88:111-118.
30. Philbin SD, Prus AJ, Pehrson AL, Porter JH (2005). Serotonin receptor mechanisms mediate the discriminative stimulus properties of the atypical antipsychotic clozapine in C57BL/6 mice. Psychopharmacology 180:49-56.
31. Porter JH, McCallum SE, Varvel SA, Vann RE (2000). The discriminative stimulus properties of the atypical antipsychotic olanzapine in rats. Psychopharmacology 148:224-233.
32. Porter JH, Prus AJ, Vann RE, Varvel SA (2005). Discriminative stimulus properties of the atypical antipsychotic clozapine and the typical antipsychotic chlorpromazine in a three-choice drug discrimination procedure in rats. Psychopharmacology 178:67-77.
33. Prus AJ, Baker LE, Meltzer HY (2004). Discriminative stimulus properties of 1.25 and 5.0 mg/kg doses of clozapine in rats: examination of the role of dopamine, serotonin, and muscarinic receptor mechanisms. Pharmacol Biochem Behav 77:199-208.
34. Prus AJ, Philibin SD, Pehrson AL, Porter JH (2005). Generalization to atypical antipsychotic drugs depends on training dose in rats trained to discriminate 1.25 mg/kg clozapine versus 5.0 mg/kg clozapine versus vehicle in a threechoice drug discrimination task. Behav Pharmacol 16:511-520.
35. Prus AJ, Philibin SD, Pehrson AL, Porter JH (2006). Discriminative stimulus properties of the atypical antipsychotic drug clozapine in rats trained to discriminate 1.25 mg/kg clozapine vs. 5.0 mg/kg clozapine vs. vehicle. Behav Pharmacol 17:185-194.
36. Smith JA, Goudie AJ (2002). Discriminative stimulus properties in rats of the novel antipsychotic quetiapine. Exp Clin Psychopharmacol 10:376-384.
37. Stolerman IP, Rauch RJ, Norris EA (1987). Discriminative stimulus effects of a nicotine-midazolam mixture in rats. Psychopharmacology 93:250-256.
38. Tang AH, Franklin SR, Himes CS, Smith MW, Tenebrink RE (1997). PNU-96415E, a potential antipsychotic agent with clozapine-like pharmacological properties. J Pharmacol Exp Ther 281:440-447.
39. Willeit M, Ginovart N, Kapur S, Houle S, Hussey D, Seeman P,Wilson AA (2006). High-affinity states of human brain dopamine D2/3 receptors imaged by the agonist [11C]-( +)-PHNO. Biol Psychiatry 59:389-394.
40. Zuch CL, Cory-Slechta DA (2001). Stimulus properties of 7-OH-DPAT versus auto- and postsynaptic receptor-specific doses of quinpirole. Pharmacol Biochem Behav 68:469-479.